Financial reports
ARS
2023 FY
Annual report to shareholders
26 Apr 24
10-K
2023 FY
Annual report
7 Mar 24
10-Q
2023 Q3
Quarterly report
7 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
9 May 23
ARS
2022 FY
Annual report to shareholders
8 May 23
10-K
2022 FY
Annual report
8 Mar 23
10-Q
2022 Q3
Quarterly report
8 Nov 22
10-Q
2022 Q2
Quarterly report
2 Aug 22
10-Q
2022 Q1
Quarterly report
10 May 22
Current reports
8-K
Departure of Directors or Certain Officers
3 Apr 24
8-K
Entry into a Material Definitive Agreement
13 Mar 24
8-K
Evolus Reports Record Fourth Quarter and Full Year 2023 Financial Results; Reaffirms 2024 Guidance
7 Mar 24
8-K
Evolus Announces Preliminary Unaudited Fourth Quarter
16 Jan 24
8-K
Evolus Enters into Licensing Agreement with Symatese to Exclusively Distribute Next-Generation Dermal Fillers in Europe
20 Dec 23
8-K
Evolus Reports Record Third Quarter 2023 Financial Results
7 Nov 23
8-K
Evolus Reports Second Quarter 2023 Results
2 Aug 23
8-K
Results of Operations and Financial Condition
27 Jul 23
8-K
Amendments to Articles of Incorporation or Bylaws
14 Jun 23
8-K
Evolus Reports First Quarter 2023 Results
9 May 23
Registration and prospectus
424B5
Prospectus supplement for primary offering
11 Mar 24
S-8
Registration of securities for employees
7 Mar 24
S-8
Registration of securities for employees
6 Oct 23
424B5
Prospectus supplement for primary offering
9 Jun 23
S-3/A
Shelf registration (amended)
7 Jun 23
S-3/A
Shelf registration (amended)
14 Apr 23
S-3
Shelf registration
8 Mar 23
S-8
Registration of securities for employees
8 Mar 23
S-8
Registration of securities for employees
9 Sep 22
S-8
Registration of securities for employees
4 Mar 22
Proxies
DEFA14A
Additional proxy soliciting materials
26 Apr 24
DEF 14A
Definitive proxy
26 Apr 24
DEF 14A
Definitive proxy
8 May 23
PRE 14A
Preliminary proxy
26 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
26 Apr 21
DEF 14A
Definitive proxy
26 Apr 21
DEFA14A
Additional proxy soliciting materials
21 Apr 20
DEFA14A
Additional proxy soliciting materials
17 Mar 20
Other
EFFECT
Notice of effectiveness
9 Jun 23
CORRESP
Correspondence with SEC
7 Jun 23
CORRESP
Correspondence with SEC
14 Apr 23
UPLOAD
Letter from SEC
30 Mar 23
UPLOAD
Letter from SEC
20 Sep 19
CORRESP
Correspondence with SEC
12 Aug 19
UPLOAD
Letter from SEC
6 Aug 19
EFFECT
Notice of effectiveness
16 Apr 19
CORRESP
Correspondence with SEC
11 Apr 19
CORRESP
Correspondence with SEC
10 Apr 19
Ownership
4
DAVID MOATAZEDI
29 Mar 24
4
Rui Avelar
21 Mar 24
4
Sandra Beaver
21 Mar 24
4
DAVID MOATAZEDI
21 Mar 24
4
DAVID MOATAZEDI
23 Feb 24
4
Rui Avelar
23 Feb 24
4
Sandra Beaver
23 Feb 24
SC 13G
Nantahala Capital Management, LLC
14 Feb 24
SC 13G/A
PERCEPTIVE ADVISORS LLC
14 Feb 24
SC 13G/A
TANG CAPITAL PARTNERS LP
14 Feb 24